KRAS and cancer: Interestingly, we discovered that the stable expression of EGFP-K-Ras(V12) resulted in reduced PI3-K p85α as well as Akt1 and Akt2 expression, but increased Akt3 expression in PANC-1 as well as Colo-699 cancer cells.